Development of radiopharmaceuticals for diagnosis of the brain and cancer by positron emission on tomography
全件表示
論文 (383件):
Kenji Ishibashi, Yoshiharu Miura, Kei Wagatsuma, Jun Toyohara, Kiichi Ishiwata, Kenji Ishii. Adenosine A 2A Receptor Occupancy by Caffeine After Coffee Intake in Parkinson's Disease. Movement Disorders. 2022. 37. 4. 853-857
Jun Toyohara, Muneyuki Sakata, Kei Wagatsuma, Tetsuro Tago, Kenji Ishibashi, Kenji Ishii, Philip Elsinga, Kiichi Ishiwata. Test-retest reproducibility of cerebral adenosine A2A receptor quantification using [11C]preladenant. Annals of Nuclear Medicine. 2021
Kenji Ishibashi, Yoshiharu Miura, Kei Wagatsuma, Jun Toyohara, Kiichi Ishiwata, Kenji Ishii. Adenosine A2A Receptor Occupancy by Long-Term Istradefylline Administration in Parkinson's Disease. Movement disorders : official journal of the Movement Disorder Society. 2021. 36. 1. 268-269
Jun Toyohara, Norihiro Harada, Takeharu Kakiuchi, Hiroyuki Ohba, Masakatsu Kanazawa, Tetsuro Tago, Muneyuki Sakata, Kiichi Ishiwata. Synthesis and evaluation of N-isopropyl-p-[11C]methylamphetamine as a novel cerebral blood flow tracer for positron emission tomography. EJNMMI research. 2020. 10. 1. 115-115
Jun Toyohara, Tetsuro Tago, Mayumi Okamoto, Kiichi Ishiwata, Kenji Ishii. Development of a novel cerebral blood flow PET tracer for diagnosis of dementia with diabetes mellitus. JOURNAL OF NUCLEAR MEDICINE. 2017. 58